Covered recipient · General Payments record
WONHEE WOO
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2020–2022
$2,024.85
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $880.25 | 10 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Grifols USA, LLC | $207.16 | 2 |
| PFIZER INC. | $128.98 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $106.67 | 1 |
| GENZYME CORPORATION | $105.29 | 1 |
| Acerta Pharma LLC | $99.51 | 1 |
| Horizon Pharma plc | $86.70 | 1 |
| Genentech, Inc. | $83.41 | 2 |
| BAXTER HEALTHCARE | $62.53 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $99.51 | 02/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 914699025 | CMS |
| Baxter Healthcare | $62.53 | 04/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | 888413303 | CMS |
| Genentech, Inc. | $18.33 | 04/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | 950783995 | CMS |
| Genentech, Inc. | $65.08 | 04/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 950783997 | CMS |
| GENZYME CORPORATION | $105.29 | 04/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939109547 | CMS |
| Grifols USA, LLC | $117.73 | 01/20/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918673221 | CMS |
| Grifols USA, LLC | $89.43 | 05/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918692693 | CMS |
| Horizon Therapeutics plc | $86.70 | 02/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 937713825 | CMS |
| PFIZER INC. | $128.98 | 06/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 949547699 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $106.67 | 02/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 955880855 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022
- Source files
- Dataset page · Bulk file · PY2020 , PY2021 , PY2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.